660MO First-in-human study of SGN-B7H4V, a B7-H4-directed vedotin ADC, in patients with advanced solid tumors: Preliminary results of a phase I study (SGNB7H4V-001)
Cesar A. Perez, Jason T. Henry, Nehal J. Lakhani, Justin Call, Erika Hamilton, Gerardo Colón‐Otero, Jennifer R. Diamond, Bert H. O’Neil, A. Kalyan, Guru Sonpavde, Irene Moreno Candilejo, Arif Awan, Elisa Fontana, Pengfei Xu, Fumin Zhang, Natalya Nazarenko, Amita Patnaik
Topics & Concepts
MedicineNeutropeniaTolerabilityInternal medicineFebrile neutropeniaResponse Evaluation Criteria in Solid TumorsPhases of clinical researchPharmacokineticsGastroenterologyAdverse effectOncologyChemotherapyMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical MethodsCAR-T cell therapy research